DILLARD'S, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DILLARD'S, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $6.56B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $6.59B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $6.87B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $7.00B | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $6.62B | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $4.43B | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $6.34B | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | $6.50B | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $6.42B | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $6.42B | Mar 29, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $6.47B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $6.48B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $6.75B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $6.87B | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $6.49B | Mar 29, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 2, 2019 | $2.01B | Mar 29, 2019 |
| FY2018 | Nov 3, 2018 | $1.42B | Mar 29, 2019 |
| FY2018 | Aug 4, 2018 | $1.47B | Mar 29, 2019 |
| FY2018 | May 5, 2018 | $1.46B | Mar 29, 2019 |
| FY2017 | Feb 3, 2018 | $2.06B | Mar 30, 2018 |
| FY2017 | Oct 28, 2017 | $1.35B | Mar 30, 2018 |
| FY2017 | Jul 29, 2017 | $1.43B | Mar 30, 2018 |
| FY2017 | Apr 29, 2017 | $1.42B | Mar 30, 2018 |
| FY2016 | Jan 28, 2017 | $1.94B | Mar 24, 2017 |
| FY2016 | Oct 29, 2016 | $1.37B | Mar 24, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $2.56B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $2.56B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $2.72B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $2.89B | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $2.75B | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $1.23B | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | $573.49M | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $461.53M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | $394.85M | Mar 31, 2020 |
| FY2019 | May 4, 2019 | $537.67M | Mar 31, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $570.19M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $593.48M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $738.85M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $891.64M | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $862.47M | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | ($71.65M) | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | $67.69M | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $5.46M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | ($40.67M) | Mar 31, 2020 |
| FY2019 | May 4, 2019 | $78.60M | Mar 31, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.76B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $1.73B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $1.72B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $1.67B | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $1.54B | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $1.21B | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $1.69B | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | $1.69B | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $1.68B | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $1.65B | Mar 29, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $717.01M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $714.13M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $883.59M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $948.39M | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $1.28B | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $252.95M | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $365.07M | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | $367.29M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $274.29M | Mar 31, 2020 |
| FY2010 | Jan 29, 2011 | $512.92M | Mar 23, 2011 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $93.38M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $104.55M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $132.94M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $120.11M | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $104.36M | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $60.45M | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $103.38M | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | $137.06M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $130.46M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $104.82M | Mar 29, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.51B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $3.53B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $3.45B | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $3.33B | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $3.25B | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $3.09B | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $3.43B | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | $3.43B | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $3.68B | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $3.90B | Mar 29, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.78B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $1.80B | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $1.70B | Mar 27, 2026 |
| FY2025 | Jan 28, 2023 | $1.60B | Mar 27, 2026 |
| FY2024 | Jan 29, 2022 | $1.45B | Mar 28, 2025 |
| FY2023 | Jan 30, 2021 | $1.44B | Mar 29, 2024 |
| FY2022 | Feb 1, 2020 | $1.62B | Mar 27, 2023 |
| FY2021 | Feb 2, 2019 | $1.68B | Mar 29, 2022 |
| FY2020 | Feb 3, 2018 | $1.71B | Mar 29, 2021 |
| FY2019 | Jan 28, 2017 | $1.72B | Mar 31, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $6.31B | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $6.23B | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $6.05B | Mar 28, 2025 |
| FY2023 | Jan 28, 2023 | $5.65B | Mar 29, 2024 |
| FY2022 | Jan 29, 2022 | $5.03B | Mar 27, 2023 |
| FY2021 | Jan 30, 2021 | $4.47B | Mar 29, 2022 |
| FY2020 | Feb 1, 2020 | $4.56B | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $4.46B | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $4.37B | Mar 29, 2019 |
| FY2017 | Jan 28, 2017 | $4.15B | Mar 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $861.46M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $717.85M | Mar 27, 2026 |
| FY2024 | Feb 3, 2024 | $808.29M | Mar 28, 2025 |
| FY2023 | Jan 28, 2023 | $650.34M | Mar 29, 2024 |
| FY2022 | Jan 29, 2022 | $716.76M | Mar 27, 2023 |
| FY2021 | Jan 30, 2021 | $360.34M | Mar 29, 2022 |
| FY2020 | Feb 1, 2020 | $277.08M | Mar 29, 2021 |
| FY2019 | Feb 2, 2019 | $123.51M | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $187.03M | Mar 29, 2019 |
| FY2018 | Jan 28, 2017 | $346.99M | Mar 29, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Feb 2, 2013 | $614.79M | Mar 28, 2013 |
| FY2011 | Jan 28, 2012 | $691.57M | Mar 22, 2012 |
| FY2011 | Jan 29, 2011 | $746.41M | Mar 22, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 36 | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | 36 | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | 44 | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | 50 | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | 41 | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | (3) | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | 4 | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | 6 | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | 7 | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | 4 | Mar 29, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 36 | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | 36 | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | 44 | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | 50 | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | 41 | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | (3) | Mar 27, 2023 |
| FY2019 | Feb 1, 2020 | 2 | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | (1) | Mar 31, 2020 |
| FY2019 | May 4, 2019 | 2 | Mar 31, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $484.88M | Mar 27, 2026 |
| FY2025 | Feb 1, 2025 | $413.80M | Mar 27, 2026 |
| FY2025 | Feb 3, 2024 | $338.63M | Mar 27, 2026 |
| FY2024 | Jan 28, 2023 | $271.31M | Mar 28, 2025 |
| FY2023 | Jan 29, 2022 | $305.24M | Mar 29, 2024 |
| FY2022 | Jan 30, 2021 | $13.98M | Mar 27, 2023 |
| FY2021 | Feb 1, 2020 | $11.52M | Mar 29, 2022 |
| FY2020 | Feb 2, 2019 | $11.11M | Mar 29, 2021 |
| FY2019 | Feb 3, 2018 | $9.42M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $9.79M | Mar 29, 2019 |